246 related articles for article (PubMed ID: 210938)
1. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
2. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
3. Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Cho-Chung YS; Redler BH; Lewallen RP
Cancer Res; 1978 Oct; 38(10):3405-9. PubMed ID: 210937
[No Abstract] [Full Text] [Related]
4. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase.
Cho-Chung YS; Clair T; Shepheard C
Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567
[TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors.
Shafie SM; Cho-Chung YS; Gullino PM
Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
Cho-Chung YS
Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
[No Abstract] [Full Text] [Related]
7. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression.
Lee C
J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705
[TBL] [Abstract][Full Text] [Related]
8. Arrest of hormone-dependent mammary cancer growth in vivo and in vitro by cholera toxin.
Cho-Chung YS; Clair T; Shepheard C; Berghoffer B
Cancer Res; 1983 Apr; 43(4):1473-6. PubMed ID: 6299521
[TBL] [Abstract][Full Text] [Related]
9. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.
Cho-Chung YS; Clair T; Schwimmer M; Steinberg L; Rego J; Grantham F
Cancer Res; 1981 May; 41(5):1840-6. PubMed ID: 7214351
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression.
Cho-Chung YS; Bodwin JS; Clair T
Eur J Biochem; 1978 May; 86(1):51-60. PubMed ID: 207518
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3',5'-monophosphate and modulation of gene expression and inhibition of binding of 7,12-dimethylbenz(alpha)anthracene to DNA of mammary cells.
Huang FL; Hasuma T; Cho-Chung YS
Cancer Res; 1984 Apr; 44(4):1595-9. PubMed ID: 6322981
[TBL] [Abstract][Full Text] [Related]
12. Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors.
Foecking MK; Abou-Issa H; Webb TE; Minton JP
J Natl Cancer Inst; 1983 Oct; 71(4):773-8. PubMed ID: 6312151
[TBL] [Abstract][Full Text] [Related]
13. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
14. Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression.
Cho-Chung YS; Redler BH
Science; 1977 Jul; 197(4300):272-5. PubMed ID: 195337
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors in androgen-induced breast tumor regression.
Zava DT; McGuire WL
Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
17. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomas.
Ogreid D; Cho-Chung YS; Ekanger R; Vintermyr O; Haavik J; Døskeland SO
Cancer Res; 1987 May; 47(10):2576-82. PubMed ID: 3032409
[TBL] [Abstract][Full Text] [Related]
19. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
[TBL] [Abstract][Full Text] [Related]
20. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours.
Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI
Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
